PURPOSE: To determine the concentration of group IIA phospholipase A2 (GIIAPLA(2)) in tears of patients with keratoconjunctivitis sicca (KCS) and to compare it with the GIIAPLA(2) content of tears in age-matched healthy controls. METHODS: The GIIAPLA(2)content of tears was measured with time-resolved fluoroimmunoassay in 20 patients with KCS (mean age 70.7+/-8.7 years) and in 20 normal subjects (mean age 70.2+/-9.9 years). RESULTS: The GIIAPLA(2)content of tears in patients with KCS was 75.8+/-54.2 microg/ml and in normal subjects it was 34.2+/-21.4 microg/ml. The difference was statistically significant. In patients with KCS the GIIAPLA(2) concentration slightly increased with decreasing Schirmer test values (Spearman's correlation =-0.20) CONCLUSION: The results of this study indicate that in patients with KCS the relative concentration of GIIAPLA(2) of tears was increased due to decreased aqueous production in the lacrimal glands and better preservation of the acinar cells in the central parts of the lobules of the lacrimal glands producing GIIAPLA(2).
PURPOSE: To determine the concentration of group IIA phospholipase A2 (GIIAPLA(2)) in tears of patients with keratoconjunctivitis sicca (KCS) and to compare it with the GIIAPLA(2) content of tears in age-matched healthy controls. METHODS: The GIIAPLA(2)content of tears was measured with time-resolved fluoroimmunoassay in 20 patients with KCS (mean age 70.7+/-8.7 years) and in 20 normal subjects (mean age 70.2+/-9.9 years). RESULTS: The GIIAPLA(2)content of tears in patients with KCS was 75.8+/-54.2 microg/ml and in normal subjects it was 34.2+/-21.4 microg/ml. The difference was statistically significant. In patients with KCS the GIIAPLA(2) concentration slightly increased with decreasing Schirmer test values (Spearman's correlation =-0.20) CONCLUSION: The results of this study indicate that in patients with KCS the relative concentration of GIIAPLA(2) of tears was increased due to decreased aqueous production in the lacrimal glands and better preservation of the acinar cells in the central parts of the lobules of the lacrimal glands producing GIIAPLA(2).
Authors: Yi Wei; Seth P Epstein; Shima Fukuoka; Neil P Birmingham; Xiu-Min Li; Penny A Asbell Journal: Invest Ophthalmol Vis Sci Date: 2011-07-01 Impact factor: 4.799
Authors: Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones Journal: Ocul Surf Date: 2017-07-20 Impact factor: 5.033
Authors: Heikki Peuravuori; Osmo Kari; Sirje Peltonen; Valtteri V Aho; Jukka M Saari; Yrjö Collan; Marko Määttä; K Matti Saari Journal: Graefes Arch Clin Exp Ophthalmol Date: 2004-06-26 Impact factor: 3.117
Authors: Heikki Peuravuori; Valtteri V Aho; Heikki J Aho; Yrjö Collan; K Matti Saari Journal: Graefes Arch Clin Exp Ophthalmol Date: 2005-07-26 Impact factor: 3.117
Authors: Solange Landreville; Stéphanie Coulombe; Patrick Carrier; Michael H Gelb; Sylvain L Guérin; Christian Salesse Journal: Invest Ophthalmol Vis Sci Date: 2004-11 Impact factor: 4.799
Authors: Valtteri V Aho; Ville Paavilainen; Timo J Nevalainen; Heikki Peuravuori; K Matti Saari Journal: Graefes Arch Clin Exp Ophthalmol Date: 2003-01-25 Impact factor: 3.117
Authors: Srihari Narayanan; Rachel L Redfern; William L Miller; Kelly K Nichols; Alison M McDermott Journal: Ocul Surf Date: 2013-01-29 Impact factor: 5.033
Authors: Sin Man Lam; Louis Tong; Xinrui Duan; U Rajendra Acharya; Jen Hong Tan; Andrea Petznick; Markus R Wenk; Guanghou Shui Journal: J Lipid Res Date: 2014-07-03 Impact factor: 5.922
Authors: Rachel L Redfern; Nimesh Patel; Samuel Hanlon; William Farley; Margaret Gondo; Stephen C Pflugfelder; Alison M McDermott Journal: Invest Ophthalmol Vis Sci Date: 2013-02-28 Impact factor: 4.799